Glottic Carcinoma: Clinical Trials

3 trials for Glottic Carcinoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 recruiting, 1 unknown. 3 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable3Completed 1, Recruiting 1, Unknown 1

Follow Glottic Carcinoma: new trials by email Literature Review of Glottic Carcinoma trials Research Report on Glottic Carcinoma

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Precision Medicine: MRI-Guided Stereotactic Ablative Radiotherapy (MRI-SABR) for Early-Stage Glottic Laryngeal Cancer
Transoral CO₂ laser cordectomy (Type I-VI depending on tumor localization), VMAT radiotherapy, MRI-SABR - Laryngeal Neoplasm, Glottic Carcinoma
Not applicableRecruitingViktoras Rudzianskas1052024-09-012026-02-05
Vocal Cord vs Whole Laryngeal Radiotherapy for T1aN0 Glottic Cancer
Hypofractionated single vocal cord irradiation, Whole laryngeal radiotherapy - Larynx Cancer Stage I, Glottic Carcinoma
Not applicableUnknownNational Cancer Institute, Egypt502020-01-012023-01-11
Stereotactic Ablative Radiotherapy for Early-stage Glottic Larynx Cancer
Radiation therapy - Glottic Carcinoma
Not applicableCompletedUniversity of Texas Southwestern Medical Center252018-05-152025-05-22

Narrower conditions

Laryngeal Neoplasms (2)  ·  Laryngeal Diseases (1)

Broader conditions

Head and Neck Neoplasms (2)  ·  Neoplasms (2)  ·  Neoplasms by Site (2)  ·  Otorhinolaryngologic Diseases (2)  ·  Otorhinolaryngologic Neoplasms (2)  ·  Respiratory Tract Diseases (2)  ·  Respiratory Tract Neoplasms (2)  ·  Laryngeal Diseases (1)

Interventions

Radiotherapy (1)

Sponsors

National Cancer Institute, Egypt (1)  ·  University of Texas Southwestern Medical Center (1)  ·  Viktoras Rudzianskas (1)

Countries

Egypt (1)  ·  Lithuania (1)  ·  United States (1)

Top investigators

David Sher, MD (1)  ·  Mohamed Mortada Elsharief (1)  ·  Tarek Shouman (1)

Results publications

PMID 32890609, PMID 41520731